193 related articles for article (PubMed ID: 8896481)
1. The costs of managing lower limb-threatening ischaemia.
Singh S; Evans L; Datta D; Gaines P; Beard JD
Eur J Vasc Endovasc Surg; 1996 Oct; 12(3):359-62. PubMed ID: 8896481
[TBL] [Abstract][Full Text] [Related]
2. Surgery for limb threatening ischaemia: a reappraisal of the costs and benefits.
Johnson BF; Evans L; Drury R; Datta D; Morris-Jones W; Beard JD
Eur J Vasc Endovasc Surg; 1995 Feb; 9(2):181-8. PubMed ID: 7627652
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment for chronic critical leg ischaemia: a 5 year follow-up of socioeconomic outcome.
Luther M
Eur J Vasc Endovasc Surg; 1997 May; 13(5):452-9. PubMed ID: 9166267
[TBL] [Abstract][Full Text] [Related]
4. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis.
Forbes JF; Adam DJ; Bell J; Fowkes FG; Gillespie I; Raab GM; Ruckley CV; Bradbury AW;
J Vasc Surg; 2010 May; 51(5 Suppl):43S-51S. PubMed ID: 20435261
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of the effect of limb-threatening ischaemia and its surgical treatment on the quality of life.
Johnson BF; Singh S; Evans L; Drury R; Datta D; Beard JD
Eur J Vasc Endovasc Surg; 1997 Mar; 13(3):306-14. PubMed ID: 9129605
[TBL] [Abstract][Full Text] [Related]
6. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Raab G; Ruckley CV
Health Technol Assess; 2010 Mar; 14(14):1-210, iii-iv. PubMed ID: 20307380
[TBL] [Abstract][Full Text] [Related]
7. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft.
Sachs T; Pomposelli F; Hamdan A; Wyers M; Schermerhorn M
J Vasc Surg; 2011 Oct; 54(4):1021-1031.e1. PubMed ID: 21880457
[TBL] [Abstract][Full Text] [Related]
8. Management cost of acute limb ischaemia.
Braithwaite BD; Jones L; Heather BP; Birch PA; Earnshaw JJ
Br J Surg; 1996 Oct; 83(10):1390-3. PubMed ID: 8944437
[TBL] [Abstract][Full Text] [Related]
9. Perioperative and rehabilitative outcomes after amputation for ischaemic leg gangrene.
Peng CW; Tan SG
Ann Acad Med Singap; 2000 Mar; 29(2):168-72. PubMed ID: 10895333
[TBL] [Abstract][Full Text] [Related]
10. Critical limb ischaemia in patients over 80 years of age: options in a district general hospital.
Humphreys WV; Evans F; Watkin G; Williams T
Br J Surg; 1995 Oct; 82(10):1361-3. PubMed ID: 7489165
[TBL] [Abstract][Full Text] [Related]
11. Outcome and cost analysis after femorocrural and femoropedal grafting for critical limb ischaemia.
Panayiotopoulos YP; Tyrrell MR; Owen SE; Reidy JF; Taylor PR
Br J Surg; 1997 Feb; 84(2):207-12. PubMed ID: 9052436
[TBL] [Abstract][Full Text] [Related]
12. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia.
Nasr MK; McCarthy RJ; Hardman J; Chalmers A; Horrocks M
Eur J Vasc Endovasc Surg; 2002 May; 23(5):398-403. PubMed ID: 12027466
[TBL] [Abstract][Full Text] [Related]
13. Results and resource implications of treating end-stage limb ischaemia.
Holdsworth RJ; McCollum PT
Eur J Vasc Endovasc Surg; 1997 Feb; 13(2):164-73. PubMed ID: 9091150
[TBL] [Abstract][Full Text] [Related]
14. Contemporary management of critical lower limb ischemia in TASC D lesions with subintimal angioplasty in femoro-popliteal lesions, tibial angioplasty and sequential compression biomechanical device for infra-inguinal arterial occlusion. Experience and quality of life outcome learned over 25 years.
Sultan S; Hynes N
J Cardiovasc Surg (Torino); 2014 Dec; 55(6):813-25. PubMed ID: 25216216
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of critical limb ischaemia in the French West Indies.
Deneuville M
West Indian Med J; 1998 Sep; 47(3):94-7. PubMed ID: 9861859
[TBL] [Abstract][Full Text] [Related]
16. Cost-efficacy issues in the treatment of peripheral vascular disease: primary amputation or revascularization for limb-threatening ischemia.
Perler BA
J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):111S-115S. PubMed ID: 8770853
[TBL] [Abstract][Full Text] [Related]
17. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia.
Awad S; Karkos CD; Serrachino-Inglott F; Cooper NJ; Butterfield JS; Ashleigh R; Nasim A
Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):51-9. PubMed ID: 16488631
[TBL] [Abstract][Full Text] [Related]
18. Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis.
Gupta SK; Veith FJ; Ascer E; Flores SA; Gliedman ML
Eur J Vasc Surg; 1988 Jun; 2(3):151-4. PubMed ID: 3410063
[TBL] [Abstract][Full Text] [Related]
19. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease.
Kalbaugh CA; Taylor SM; Blackhurst DW; Dellinger MB; Trent EA; Youkey JR
J Vasc Surg; 2006 Aug; 44(2):296-302; discussion 302-3. PubMed ID: 16814976
[TBL] [Abstract][Full Text] [Related]
20. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
